NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorWest Virginia University
About this trial
This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk, completing risk assessments, safety planning, lethal means restriction, follow-up referrals, and other disposition planning as appropriate.
Investigators aim to do the following:
1. Gather formative data from providers, parents, and youth to inform ways to adapt and implement the NIMH Clinical Pathway so that it can be effectively implemented in rural, Appalachian School-Based Health Centers (SBHCs). 2. Gather preliminary data regarding the feasibility, acceptability, and effectiveness of the adapted intervention.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Youth who are receiving services at the school-based health centers to participate
Parents must be able to give legal consent for themselves and their children to participate
Youth and Parent must be English-speaking
Youth must also be able to give signed assent to participate
Disqualifiers
Youth in state custody will be excluded from study participation due to challenges related to obtaining legal consent.
Trial design
Design model
Parallel
Treatments tested in this trial
NIMH Clinical Pathway
BehavioralComplete the implemented workflow and tools for suicide risk screening, assessment, safety planning and follow-up.
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: Treatment As Usual (TAU)No intervention 0 interventions
Group B: NIMH Clinical PathwayActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Number of Patients Screened for Suicidal Risks-Site 1
Review of patient records for the number of patients that were asked about suicidal thoughts and/or behaviors during their visit. Review will occur for a total of 3 months during the Treatment as Usual Period.
Time frame
Total period of 3 Months2
Number of Patients Screened for Suicidal Risks-Site 2
Review of patient records for the number of patients that were asked about suicidal thoughts and/or behaviors during their visit. Review will occur for a total of 6 months during the Treatment as Usual Period.
Time frame
Total period of 6 Months3
Number of Patients Reporting Suicidal Risks-Site 1
Review of patient records for the number of patients that reported having suicidal thoughts and/or behaviors. Review will occur for a total of 12 months during the Intervention Period.
Time frame
Total period of 12 Months4
Number of Patients Reporting Suicidal Risks-Site 2
Review of patient records for the number of patients that reported having suicidal thoughts and/or behaviors. Review will occur for a total of 12 months during the Interventional Period
Time frame
Total period of 12 MonthsSecondary outcomes
1
Safety Planning Rates (Number)- Site 1
Number of at-risk patients that the providers documented safety planning was completed.
Time frame
Initial Visit2
Safety Planning Rates (Number)- Site 1
Number of at-risk patients that the providers documented safety planning was completed.
Time frame
3 Month Follow Up Visit3
Safety Planning Rates (Number)- Site 2
Number of at-risk patients that the providers documented safety planning was completed.
Time frame
Initial Visit4
Safety Planning Rates (Number)- Site 2
Number of at-risk patients that the providers documented safety planning was completed.
Time frame
3 Month Follow Up VisitSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov